
デジタル革命でより包摂的なヘルスケアの実現を
ヘルスケアは、デジタル革命を迎えています。ビッグデータやモバイル機器など、革新的な技術がヘルスケアの新たな可能性を切り拓くというこの動きは、新型コロナウイルスのパンデミック(世界的大流行)でより顕著になりました。スマートフォンのアプリはウイルスの拡散を追跡し、AI(人工知能)は、医師がウイルスによる肺炎の兆候を見つけるのに役立っています。
Takeda (TSE:4502/NYSE:TAK), a global values-based R&D-driven biopharmaceutical leader headquartered in Japan, translates science into innovative medicines. It focuses its R&D efforts on four therapeutic areas: oncology, rare diseases, neuroscience and gastroenterology. It also makes R&D investments in plasma-derived therapies and vaccines. Takeda is focusing on developing innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging enhanced collaborative R&D engines and capabilities to create a modality-diverse pipeline. Its employees are committed to improving quality of life for patients and to working with healthcare partners in some 80 countries.